Skip to main content
. 2022 Jun 16;134:18–24. doi: 10.1016/j.pediatrneurol.2022.06.007

TABLE.

Patient Overview

Patient No. Sex Age Progression of COVID-19 Infection Cerebrovascular Complications The Time Interval of Complications After COVID-19 Infection Antigen/PCR COVID-19 Test Result at Hospital Admission COVID-19 Antibody Results and Time Span After Infection Thrombotic/Hemophilic Risk Factors Therapy Neurological Outcome
Patient I M 12 Asymptomatic Meningitis with subdural hemorrhage Acute Negative Positive 2 month after infection None Neurosurgical, CS Normal
Patient II F 1 Asymptomatic Vasculitis with brainstem involvement 3 months Negative Positive 3 months after infection Leiden heterozygous, elevated factor VIII CS, LMWH, ASA Mild
Patient III F 11 Repeated infection with post-COVID rhinitis, otitis media, and protanopia Lacunar ischemic stroke 1 month Negative Positive 1 month after the second infection None ASA Normal
Patient IV M 4 Asymptomatic CVT with hemorrhage—atypical PIMS-TS NA Negative NA None CS, IVIG, LMWH, Neurosurgical Moderate

Abbreviations:

ASA = Acetylsalicylic acid

CS = Corticosteroids

CVT = Cerebral venous thrombosis

F = Female

IVIG = Intravenous immunoglobulins

LMWH = Low-molecular-weight heparin

M = Male

NA = Not applicable

PIMS-TS = Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2

Ptosis, squint.

Hemiparesis, facial nerve paresis, vocal cord paresis.